Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06866106 · ClinicalTrials.gov registry record · NA

Well-being in IBS: Strengths and Happiness (WISH) 2.0

A NA study of Irritable Bowel Syndrome, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06866106 is a NA study of Irritable Bowel Syndrome that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 50 participants, below the 143-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06866106, a NA study of Irritable Bowel Syndrome, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the feasibility, acceptability, preliminary effects, and candidate gut-brain mechanisms of an optimized positive psychology (PP) intervention for patients with irritable bowel syndrome (IBS), entitled "WISH," compared to an educational control intervention.

Conditions Studied

Interventions

  • BEHAVIORAL Educational Intervention
  • BEHAVIORAL Positive Psychology (PP) Intervention

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-10-30
Est. Completion 2028-08
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT06866106

The ClinicalTrials.gov registry entry for NCT06866106 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 143-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (65% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Educational Intervention is the first listed.

NCT06866106 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06866106 about?

NCT06866106 is a clinical study titled "Well-being in IBS: Strengths and Happiness (WISH) 2.0". The purpose of this study is to examine the feasibility, acceptability, preliminary effects, and candidate gut-brain mechanisms of an optimized positive psychology (PP) intervention for patients with irritable bowel syndrome (IBS), entitled "WISH," compared to an educational control intervention.

What is the current status of trial NCT06866106?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-10-30. Estimated completion is 2028-08.

What conditions does trial NCT06866106 study?

This clinical trial studies the following conditions: Irritable Bowel Syndrome.

What interventions are being tested in trial NCT06866106?

The interventions under investigation include: Educational Intervention (BEHAVIORAL), Positive Psychology (PP) Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06866106?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06866106 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Irritable Bowel Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.